39.1%; p = 0.017), while CFR increase in patients with cerebrovascular diseases did not reach statistical significance (48.3% vs. 41.4%; p = 0.597).
← all excerpts
Neurological comorbidities and COVID-19-related case fatality: A cohort study.
1
0.5970
0.5970